Blood-based diagnostic testing methodology for non-invasive detection of genetic abnormalities and disease markers. Uses advanced sequencing techniques to analyze circulating DNA and genetic material.
Manufactured by
Eone-Diagnomics Genome Center
South Korea
Global NGS Company, EDGCWe provide the value for a healthy lifestyle by suggesting customized healthcare based on genome information.Through genome analysis, we have provided genetic screening tests to help people predict cancer and diseases and to offer personalized healthcare.We have developed cutting-edge diagnostic solutions that empower individuals to make informed health decisions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
Biopsense Oy
Finland · 3 relevant products
NOROVA
China · 4 relevant products
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 75 closest product alternatives
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
72 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products